Brazil maker of Sputnik V vaccine sees greenlight on tests by next week

BRASILIA (Reuters) – The Brazilian pharmaceutical company that will make Russia’s Sputnik V vaccine against COVID-19 expects regulatory approval for Phase III tests by this week or early next at the latest, its Chief Executive Officer Fernando Marques said on Tuesday.

Marques said the strong efficacy results from late stage trials in Russia, published on Tuesday by The Lancet – 91.6% effective against symptomatic COVID-19 – will help speed up approval in Brazil sought by his firm União Quimica.


By Anthony Boadle and Tatiana Bautzer via Reuters


Read full article here

Share This

Chamber Updates Stay connected with Chamber activities